BeiGene's Shanghai stock debut flops as excessive premium, running losses keep investors at bay
The biggest IPO on Star Market flopped after BeiGene shares slumped by as much as 19 per cent on the first day of trading in Shanghai. Concerns about US delisting and steep declines in its Hong Kong and Nasdaq-listed securities clouded its debut.